WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Seoul, South Korea.
Frequently asked questions
What sector does WooGene B&G Co. Ltd (018620) operate in?
WooGene B&G Co. Ltd belongs to the Healthcare sector and operates in the Pharmaceuticals industry.
What is WooGene B&G Co. Ltd (018620) current stock price?
As of the latest data, WooGene B&G Co. Ltd stock price is ₩2,715, with a previous close of ₩2,715.
What is WooGene B&G Co. Ltd (018620) current market capitalization?
WooGene B&G Co. Ltd market cap is approximately 70.50 billion.
Does WooGene B&G Co. Ltd (018620) pay dividends?
No. WooGene B&G Co. Ltd does not pay a dividend.
What is WooGene B&G Co. Ltd (018620) beta (volatility) score?
WooGene B&G Co. Ltd has a beta of 0.890, meaning its volatility is roughly in line with the market.
